MELK-expressing cells enriched from mammary tumors of MMTV-Wnt1/MELK-GFP mice have higher tumor-initiating potential both in vitro and in vivo, which is reversed upon MELK-targeting shRNA knockdown (Hebbard et al., 2010). The gene discussed is MELK; the disease is neoplasm.